{"id":"W3090227268","doi":"10.1111/bjd.19573","title":"Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial*","year":2020,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"LEO Pharma","keywords":"Medicine; Placebo; Atopic dermatitis; Double blind; Dermatology; Randomized controlled trial; Internal medicine; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002208467,0.000268959,0.002376144,0.00006115766,0.0002178874,0.00007011274,0.0003271691,0.0002115704,0.00008321685],"category_scores_gemma":[0.001338945,0.0001658134,0.0009220587,0.0001154962,0.0002990242,0.00011615,0.00002830092,0.0002872131,0.000007166065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005583829,"about_ca_system_score_gemma":0.0003679814,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009444317,"about_ca_topic_score_gemma":0.00009475412,"domain_scores_codex":[0.9964036,0.0005922684,0.002054879,0.0002706264,0.0003075966,0.0003709668],"domain_scores_gemma":[0.9937769,0.00445471,0.0008298167,0.0002759633,0.000318011,0.0003445923],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9714919,0.0009771221,0.00009350967,0.00003781326,0.002037528,0.002200966,0.002371782,0.0001032711,0.00001394564,0.00004816433,0.01375654,0.0068675],"study_design_scores_gemma":[0.9751604,0.0007375014,0.0002281549,0.000176168,0.002677931,0.01064435,0.0006067785,0.005090913,0.0006202883,0.0001346571,0.00377585,0.000146997],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9266635,0.01427589,0.004372388,0.04685624,0.0007056376,0.006742788,0.0002107522,0.00002500717,0.0001478019],"genre_scores_gemma":[0.9931586,0.002000019,0.0003847196,0.003550622,0.0004526373,0.0002953097,0.00005606428,0.00002263402,0.00007934107],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06649516,"threshold_uncertainty_score":0.6761674,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03726144453849478,"score_gpt":0.3107739583228424,"score_spread":0.2735125137843477,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}